跳至主要内容
临床试验/CTRI/2024/07/069770
CTRI/2024/07/069770尚未招募4 期

To Study Efficacy and Outcome of Emicizumab Prophylaxis in Patients of Hemophilia A - Nil

Rnt medical College0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • New Confirmed case of hemophilia A
  • Patients with a documented baseline bleeding frequency, allowing for a comparison of bleeding episodes before and after emicizumab treatment
  • Patients who give informed consent

排除标准

  • Presence of coagulation disorders other than hemophilia A, which may confound the study results
  • Significant comorbidities or medical conditions that may independently affect the outcomes of interest. Like liver diseases
  • Patients without proper informed consent

研究者

相似试验